Drawing for PRESS PLAY AND WALK AWAY

USPTO serial 77533194

PRESS PLAY AND WALK AWAY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
EVANKO, PATRICIA MALESARDI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRESS PLAY AND WALK AWAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter J. Willsey

Peter J. Willsey Cooley LLP777 6TH ST., N.W., SUITE 1100WASHINGTON, DC 20001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Amino acids for laboratory or research use; Assays and reagents for use in genetic research; Assays for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, precursors for in vitro genetic engineering use; Biological Tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Chemical preparations for scientific purposes; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Nucleic acid for laboratory use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Research reagents for industrial use, namely, for food testing; Test particles for biodetection systems, biological analogues and microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment used for analyzing air for the presence of harmful biological substancesACTIVE—
005Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humansACTIVE—
009Diagnostic apparatus for testing food; Laboratory apparatus and chromatography systems for use in protein purification; Laboratory apparatus and instruments for the exchange of substances and heat; Laboratory apparatus and instruments, namely, pre-packed columns for use in separation and purification; Scientific apparatus and instruments for measuring relative DNA/RNA and protein and parts and fittings thereforACTIVE—
010Apparatus for clinical diagnosis; Blood testing apparatus; Medical apparatus for diagnosing or treating respiratory conditions; Medical instruments, namely, biosensors for detecting infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 15, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 15, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 4, 2012ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 2, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 1, 2012EX5GSOU EXTENSION 5 GRANTED—
Feb 29, 2012EXT5SOU EXTENSION 5 FILED—
Feb 29, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 14, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 13, 2011EX4GSOU EXTENSION 4 GRANTED—
Sep 12, 2011EXT4SOU EXTENSION 4 FILED—
Sep 12, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 15, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 14, 2011EX3GSOU EXTENSION 3 GRANTED—
Mar 10, 2011EXT3SOU EXTENSION 3 FILED—
Mar 10, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 22, 2010ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 15, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 14, 2010EX2GSOU EXTENSION 2 GRANTED—
Sep 14, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 19, 2010EXT2SOU EXTENSION 2 FILED—
Aug 19, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 14, 2010ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 19, 2010EX1GSOU EXTENSION 1 GRANTED—
Feb 19, 2010EXT1SOU EXTENSION 1 FILED—
Feb 19, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 25, 2009UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
Sep 15, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 23, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2009NPUBNOTICE OF PUBLICATION—
May 19, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 19, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 6, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 6, 2009ALIEASSIGNED TO LIE—
May 5, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 5, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2008DOCKASSIGNED TO EXAMINER—
Jul 31, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance